← Back to Search

Behavioural Intervention

LEAP Program for Irritable Bowel Syndrome

N/A
Recruiting
Led By Gustavo Zarini, Ph.D., RD
Research Sponsored by Oxford Biomedical Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have IBS of at least moderate severity
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial found that a tailored anti-inflammatory eating plan, guided by a registered dietitian, improved symptoms in people with irritable bowel syndrome.

Eligible Conditions
  • Irritable Bowel Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have moderate to severe Irritable Bowel Syndrome (IBS).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Inflammatory blood markers
Secondary outcome measures
Gastrointestinal symptoms severity
The quality of life

Trial Design

1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
Individuals with Irritable Bowel Syndrome (IBS)

Find a Location

Who is running the clinical trial?

Oxford Biomedical Technologies, Inc.Lead Sponsor
Gustavo Zarini, Ph.D., RDPrincipal InvestigatorOxford Biomedical Technologies, Inc.

Media Library

Lifestyle Eating and Performance (LEAP) Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05178017 — N/A
Irritable Bowel Syndrome Research Study Groups: Participants
Irritable Bowel Syndrome Clinical Trial 2023: Lifestyle Eating and Performance (LEAP) Program Highlights & Side Effects. Trial Name: NCT05178017 — N/A
Lifestyle Eating and Performance (LEAP) Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05178017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of people partaking in this research project?

"Yes, the information provided on clinicaltrials.gov indicates that this study is actively recruiting patients and has been doing so since it was posted 9/1/2021. Currently there are 60 open positions at one location for participants in this trial."

Answered by AI

Does the age requirement for this medical study span beyond 65 years?

"This study seeks patients ranging from 18 to 75 years old; conversely, there are 381 trials seeking younger participants and 1009 aiming for older ones."

Answered by AI

Is it possible to sign up for participation in this medical research?

"This clinical trial is seeking 60 volunteers with irritable bowel syndrome, who are aged 18 to 75 and satisfy the following prerequisites: a stable dose regimen for 1 month prior to enrolment, commitment to completing the study, IBS of moderate intensity or greater, and agreement to adhere to LEAP protocol for 3 months."

Answered by AI

Are there any opportunities to join this research endeavor?

"The clinicaltrials.gov page for this trial states it is actively accepting participants, with a first posting date of September 1st 2021 and recent update on the 19th of September 2022."

Answered by AI
~17 spots leftby Mar 2025